 | | Vol. 13.37 – 22 September, 2022 |
| |
|
|
| The authors showed that tissue flow was a mechanism governing core group-independent planar cell polarity on the Drosophila notum.
[Cell Reports] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists compared quantitative gel zymography and ELISA to determine which method better discriminated abnormal matrix metalloproteases-9 levels of individuals with Fragile X Syndrome from healthy controls and correlated with the clinical profile.
[Scientific Reports] |
|
|
|
| Investigators demonstrated that the noncanonical Wnt receptor, Ror2, regulates tumor cell–driven matrix remodeling and invasion in breast cancer.
[Molecular Biology of the Cell] |
|
|
|
| In chondrocytes, treatment with XMU-MP-1 elevated the matrix metalloproteinas and decreased the ECM induced by IL-1β.
[Frontiers in Bioengineering and Biotechnology] |
|
|
|
| Researchers demonstrated that poly(butylene adipate-co-terephthalate) (PBAT) electrospun microfibrous membranes could be successfully modified with decellularized bone ECM to endow fibers with bioactive hydrogel and mimic natural micro-features of the native bone tissue.
[Macromolecular Bioscience] |
|
|
|
| Scientists developed multifibrillar yarns with superior mechanical performance based on biocompatible polyacrylonitrile as surrogate ECM.
[Macromolecular Bioscience] |
|
|
|
| Overexpression of miR-99a significantly suppressed cell apoptosis and ECM degradation stimulated by IL-6 and TNF-α.
[BMC Musculoskeletal Disorders] |
|
|
|
|
| Investigators focus on the central role of the cell, ECM, and tissue mechanics in regulating tissue repair by controlling myofibroblast action.
[Cold Spring Harbor Perspectives in Biology] |
|
|
|
| Scientists highlight the most relevant ECM components presenting a comprehensive description of their physical, cellular, and molecular properties which can alter the therapy response of tumor cells.
[Journal of Experimental & Clinical Cancer Research] |
|
|
|
| The authors summarize the effects of fibroblast growth factors (FGFs) in fibroblast to myofibroblast differentiation and ECM protein expression and the underlying potential regulatory mechanisms to provide a basis for the clinical application of recombinant FGF protein drugs in the treatment of tissue damage.
[Open Biology] |
|
|
|
|
| MiMedx Group, Inc. announced the launch of AXIOFILLâ„¢, an ECM Particulate product derived from human placental tissue. AXIOFILL is the first and only human placental-derived particulate product available for Surgical Recovery procedures.
[MiMedx Group, Inc.] |
|
|
|
|
| February 9 – 12, 2022
Cancun, Mexico |
|
|
|
|
|
| | University of Pittsburgh – Pittsburgh, Pennsylvania, United States |
|
|
|
| | University Medical Center Freiburg – Freiburg, Germany |
|
|
|
| | University Hospital of Muenster – Münster, Germany |
|
|
|
| | National University of Ireland Galway – Galway, Ireland |
|
|
|
| | Karolinska Institutet – Flemingsberg, Sweden |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
